Century Therapeutics
IPSC
67 hedge funds and large institutions have $67.8M invested in Century Therapeutics in 2024 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 16 reducing their positions, and 5 closing their positions.
120% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 5
31% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 16
10% more funds holding
Funds holding: 61 → 67 (+6)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.68% less ownership
Funds ownership: 47.48% → 46.8% (-0.68%)
12% less call options, than puts
Call options by funds: $15K | Put options by funds: $17K
34% less capital invested
Capital invested by funds: $102M → $67.8M (-$34.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.46M |
| 3 |
Renaissance Technologies
New York
|
+$632K |
| 4 |
SP
Syncona Portfolio
St Peter Port,
Guernsey
|
+$416K |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$325K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$3.88M |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$1.96M |
| 3 |
OCA
Octagon Capital Advisors
New York
|
-$1.31M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$840K |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$704K |
IPSC Hedge Fund Activity: Q3 2024 in Review
67 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Century Therapeutics (IPSC) for Q3 2024, worth a combined $67.8M — down 34% from $102M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new IPSC positions and 5 closed out — a net gain of 6 holders — while 21 added to existing stakes and 16 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $4M. The largest seller was Casdin Capital, cutting an estimated $3.88M.
- 67 institutional investors held Century Therapeutics (IPSC) as of Q3 2024, up from 61 in Q2 2024.
- Funds reported $67.8M of Century Therapeutics stock for Q3 2024, down 34% quarter-over-quarter.
- 11 funds opened new Century Therapeutics positions in Q3 2024 and 5 closed out, a net change of +6 holders.
- The largest Century Therapeutics buyer in Q3 2024 was Morgan Stanley, an estimated $4M added.
- The largest Century Therapeutics seller in Q3 2024 was Casdin Capital, an estimated $3.88M sold.
Based on aggregated 13F filings for Q3 2024.